Filing Flows › Roivant Sciences (ROIV) › Q4 FY26 › vs Q4 FY25
Roivant Sciences (ROIV) Q4 FY26 vs Q4 FY25 (year over year)
Roivant Sciences's revenue fell $5.0M (-67%) from $7.6M in Q4 FY25 to $2.5M in Q4 FY26.
Roivant Sciences, Q4 FY26: revenue $2.5M (-67% year over year), net earnings $303M, operating cash flow −$164M. The chart draws each line against Q4 FY25, the increases inside each band.
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $2.5M | $7.6M | −$5.0M | -67% |
| Other income, net | $38.9M | $81.9M | −$43.1M | -53% |
| Operating profit | $415M | −$285M | $700M | — |
| Pre-tax earnings | $454M | −$203M | $657M | — |
| Net earnings | $303M | −$206M | $509M | — |
| Minority interests | $52.8M | −$45.9M | $98.7M | — |
| Income tax | $98.4M | $49.3M | $49.0M | +99% |
| Operating cash sources | $545M | $51.0M | $494M | +968% |
| Depreciation & amortization | $638K | $1.4M | −$787K | -55% |
| Share-based compensation | $77.2M | $83.5M | −$6.3M | -8% |
| Cash used in operations | $164M | $173M | −$8.7M | -5% |
| Working capital & other | $545M | $51.0M | $494M | +968% |
Questions
How much did Roivant Sciences's revenue grow year over year in Q4 FY26?
Roivant Sciences's revenue fell $5.0M (-67%) from $7.6M in Q4 FY25 to $2.5M in Q4 FY26.